Novo Nordisk's pricing tactics during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of cost gouging, pointing out the stark distinction involving U.S. costs and those in Europe and copyright.Having said that, It can be very important to stay mindful that these cost savings mightn't apply univer